113: Yerba Mate and Metabolism - What the Science Says with Dr. Ben Bikman

Bikman cited a 2015 study on 11 healthy women who ingested 2 g of yerba mate before moderate-intensity cycling. Compared with placebo, fatty acid oxidation jumped by 24%, and the respiratory quotient (RQ) dropped significantly. RQ is a breath-derived metric where a lower number means more fat is being burned than glucose. Bikman explained that exercising muscles have limited glycogen stores, so promoting fat oxidation can sustain energy output and spare glycogen. He also noted that similar studies confirm the RQ shift, making the effect robust. The practical implication: a pre-workout yerba mate drink can help tap into the body’s virtually unlimited fat stores, potentially extending exercise endurance and increasing total fat loss over time.

Bikman detailed the study where participants took chlorogenic acid 30 minutes before a 75 g oral glucose tolerance test. The early glucose spike was lowered by 11% (statistically significant but modest). More impressive, the insulin area under the curve dropped by roughly 40%, suggesting that much less insulin was needed to handle the same glucose load. Bikman described this as 'pretty compelling' and directly proposed a use-case: timing yerba mate consumption with the highest carb meal of the day. He emphasized that the effect is likely due to chlorogenic acid's inhibition of α-glucosidase and α-amylase enzymes, which slows carbohydrate breakdown in the gut, flattening the postprandial glucose surge and reducing the demand on pancreatic β-cells. This could be especially valuable for preserving insulin sensitivity over time.

Bikman presented a 12-week randomized, double-blind, placebo-controlled trial as the gold-standard evidence for yerba mate and fat loss. Obese participants received 3 g of yerba mate extract daily without any dietary or exercise instructions. The yerba mate group lost an average of 1.5 kg of body fat, while the placebo group lost only 0.3 kg—a five-fold difference. Waist-to-hip ratio also improved, and no adverse effects were reported. This suggests that yerba mate has a specific, targeted effect on fat mass reduction, not just water or lean tissue loss. A separate six-week trial using green mate extract showed the intervention group lost 0.5 kg of fat while the placebo group gained 2 kg. Bikman used these data to argue that yerba mate can be a simple, low-risk addition to a weight-loss plan.

Bikman detailed a 2023 study from his lab that examined yerba mate supplementation across skeletal muscle, adipose tissue, and liver. In skeletal muscle, they observed improved mitochondrial coupling—more oxygen consumption translated directly into more ATP, like a car engine in drive that moves the vehicle. In white adipose tissue, the same supplementation increased mitochondrial uncoupling: oxygen consumption rose without a matching increase in ATP. The energy was dissipated as heat, analogous to revving an engine while in park. This thermogenic effect is metabolically favorable because it ‘wastes’ stored calories from fat cells. In the liver, yerba mate shifted the redox balance toward a more reduced state, suggesting enhanced antioxidant defenses. Bikman emphasized that these tissue-specific outcomes argue for a sophisticated, multi-target action of yerba mate that goes beyond simple stimulant effects.

Bikman described his lab’s 2025 publication where they explored yerba mate’s effect on GLP-1 in mice. Whole yerba mate increased GLP-1 expression in the jejunum and raised plasma GLP-1 levels. When they cultured L cells with plain yerba mate, the effect was modest. However, they identified that ferulic acid, a polyphenol in yerba mate, is metabolized by gut microbiota into dihydroferulic acid. Incubating L cells with that metabolite resulted in an almost three-fold increase in GLP-1 secretion. This elegantly demonstrated that the full GLP-1 benefit requires a healthy gut microbiome to convert ferulic acid into the more active compound. Bikman underscored that this unexpected finding highlights the interplay between diet, microbiota, and host metabolism.

Bikman walked through a fascinating hierarchy of bitter taste receptor locations: mouth (taste perception), gut (enteroendocrine cells releasing CCK, PYY, GLP-1), and most surprisingly, white adipocytes. He noted that the research is early but suggests that when these adipocyte receptors are stimulated—potentially by bitter compounds from yerba mate—they may enhance lipolysis and increase secretion of adiponectin, a beneficial insulin-sensitizing adipokine. This adds a direct fat-tissue target for yerba mate’s metabolic benefits, independent of gut hormone signaling. Bikman emphasized that this mechanism helps explain satiety and fat-burning beyond the known incretin effects, and encouraged people not to shy away from the bitter taste.

Bikman recounted that his foray into yerba mate started when he began testing various products for his lab studies. He tried Unimate, a formulation from Unicity, and found the taste vastly superior to other yerba mates he had tried. The lack of smoked leaves, high-altitude sourcing, and high chlorogenic acid content impressed him. Over time, his personal use and the accumulating metabolic evidence motivated him to lead studies in his lab. Only after using the product independently did the company approach him to be a scientific advisor, a role he accepted once the product had already proven itself in his own hands. He openly shared this timeline to underscore that his enthusiasm is rooted in both personal and laboratory experience.